Britannia Life Sciences Inc. (CSE:BLAB)
Canada
· Delayed Price · Currency is CAD 0.0900
0.00 (0.00%)
Apr 28, 2026, 1:02 PM EST
Britannia Life Sciences Market Cap
Britannia Life Sciences has a market cap or net worth of CAD 14.60 million as of April 28, 2026. Its market cap has increased by 80.00% in one year.
Market Cap
14.60M
Enterprise Value
-1.03M
Revenue
157.68K
Ranking
n/a
PE Ratio
1.84
Stock Price
0.09
Market Cap Chart
Since November 18, 2021, Britannia Life Sciences's market cap has decreased from 41.95M to 14.60M, a decrease of -65.19%. That is a compound annual growth rate of -21.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 14.60M | - |
| Dec 31, 2025 | 14.60M | 12.50% |
| Dec 19, 2024 | 12.98M | 6.67% |
| Dec 29, 2023 | 12.17M | 7.14% |
| Dec 30, 2022 | 11.36M | -60.48% |
| Dec 31, 2021 | 28.74M | -31.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rapid Dose Therapeutics | 14.33M |
| Hemostemix | 13.85M |
| PreveCeutical Medical | 11.96M |
| Pharmala Biotech Holdings | 17.97M |
| Innovotech | 10.89M |
| Marvel Biosciences | 10.71M |
| Glow Lifetech | 8.65M |
| COSCIENS Biopharma | 8.28M |